BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 28882092)

  • 1. Bayesian sensitivity analysis for unmeasured confounding in causal mediation analysis.
    McCandless LC; Somers JM
    Stat Methods Med Res; 2019 Feb; 28(2):515-531. PubMed ID: 28882092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bayesian data fusion: Probabilistic sensitivity analysis for unmeasured confounding using informative priors based on secondary data.
    Comment L; Coull BA; Zigler C; Valeri L
    Biometrics; 2022 Jun; 78(2):730-741. PubMed ID: 33527348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of Bayesian and Monte Carlo sensitivity analysis for unmeasured confounding.
    McCandless LC; Gustafson P
    Stat Med; 2017 Aug; 36(18):2887-2901. PubMed ID: 28386994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimation of Natural Indirect Effects Robust to Unmeasured Confounding and Mediator Measurement Error.
    Fulcher IR; Shi X; Tchetgen Tchetgen EJ
    Epidemiology; 2019 Nov; 30(6):825-834. PubMed ID: 31478915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mediational E-values: Approximate Sensitivity Analysis for Unmeasured Mediator-Outcome Confounding.
    Smith LH; VanderWeele TJ
    Epidemiology; 2019 Nov; 30(6):835-837. PubMed ID: 31348008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bayesian sensitivity analysis for unmeasured confounding in observational studies.
    McCandless LC; Gustafson P; Levy A
    Stat Med; 2007 May; 26(11):2331-47. PubMed ID: 16998821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjustment for unmeasured confounding through informative priors for the confounder-outcome relation.
    Groenwold RHH; Shofty I; Miočević M; van Smeden M; Klugkist I
    BMC Med Res Methodol; 2018 Dec; 18(1):174. PubMed ID: 30577773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A flexible approach for causal inference with multiple treatments and clustered survival outcomes.
    Hu L; Ji J; Ennis RD; Hogan JW
    Stat Med; 2022 Nov; 41(25):4982-4999. PubMed ID: 35948011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A flexible, interpretable framework for assessing sensitivity to unmeasured confounding.
    Dorie V; Harada M; Carnegie NB; Hill J
    Stat Med; 2016 Sep; 35(20):3453-70. PubMed ID: 27139250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Negative Control Exposures: Causal Effect Identifiability and Use in Probabilistic-bias and Bayesian Analyses With Unmeasured Confounders.
    Flanders WD; Waller LA; Zhang Q; Getahun D; Silverberg M; Goodman M
    Epidemiology; 2022 Nov; 33(6):832-839. PubMed ID: 35895515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitivity analysis for the effects of multiple unmeasured confounders.
    Groenwold RH; Sterne JA; Lawlor DA; Moons KG; Hoes AW; Tilling K
    Ann Epidemiol; 2016 Sep; 26(9):605-11. PubMed ID: 27576907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and robust estimation of swapped direct and indirect effects: Mediation analysis with unmeasured mediator-outcome confounding and intermediate confounding.
    Tai AS; Lin SH
    Stat Med; 2022 Sep; 41(21):4143-4158. PubMed ID: 35716042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simplified Bayesian sensitivity analysis for mismeasured and unobserved confounders.
    Gustafson P; McCandless LC; Levy AR; Richardson S
    Biometrics; 2010 Dec; 66(4):1129-37. PubMed ID: 20070294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Bayesian semiparametric latent variable approach to causal mediation.
    Kim C; Daniels M; Li Y; Milbury K; Cohen L
    Stat Med; 2018 Mar; 37(7):1149-1161. PubMed ID: 29250817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing mediation using marginal structural models in the presence of confounding and moderation.
    Coffman DL; Zhong W
    Psychol Methods; 2012 Dec; 17(4):642-64. PubMed ID: 22905648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monte Carlo sensitivity analysis for unmeasured confounding in dynamic treatment regimes.
    Rose EJ; Moodie EEM; Shortreed SM
    Biom J; 2023 Jun; 65(5):e2100359. PubMed ID: 37017498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing the impact of unmeasured confounding for binary outcomes using confounding functions.
    Kasza J; Wolfe R; Schuster T
    Int J Epidemiol; 2017 Aug; 46(4):1303-1311. PubMed ID: 28338913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. G-computation demonstration in causal mediation analysis.
    Wang A; Arah OA
    Eur J Epidemiol; 2015 Oct; 30(10):1119-27. PubMed ID: 26537707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [How to adjust confounders in studies on observational comparative effectiveness: (3) approaches on sensitivity analysis for confounder adjustment].
    Huang LL; Zhao Y; Wei YY; Chen F
    Zhonghua Liu Xing Bing Xue Za Zhi; 2019 Dec; 40(12):1645-1649. PubMed ID: 32062931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing the impact of unmeasured confounders for credible and reliable real-world evidence.
    Zhang X; Stamey JD; Mathur MB
    Pharmacoepidemiol Drug Saf; 2020 Oct; 29(10):1219-1227. PubMed ID: 32929830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.